GlaxoSmithKline plc said it acquired the rights to sell over-the-counter (OTC) marketing rights of Merck's cholesterol lowering drug Mevacor (lovastatin) in the US.
Read More...
[Source: Yahoo! News Search Results for liver disease help]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment